ENDONOVO THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Increase (Decrease) in Accrued Liabilities of $623.88 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2019-04-15
- ENDONOVO THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2018 was $623.88K, a 103.98% increase from fiscal 2017.
- ENDONOVO THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2017 was $305.85K.
- ENDONOVO THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2011 was $549.00.
- ENDONOVO THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2010 was $0.00.
| Period end | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|
| 2018-12-31 | $623.88K 10-K · filed 2019-04-15 |
| 2017-12-31 | $305.85K 10-K · filed 2019-04-15 |
| 2011-12-31 | $549.00 10-K · filed 2012-04-13 |
| 2010-12-31 | $0.00 10-K · filed 2012-04-13 |